Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DA-3002 vs Genotropin in short children born SGA
NCT02770157Phase 3Completed
- Sponsor
- Dong-A ST
- Start
- Feb 2016
- Primary completion
- Aug 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Growtropin-II in short stature, Small for gestational age (SGA), sponsored by Dong-A ST. Started Feb 2016; status: completed.
02
Drugs
Growtropin-II
03
Conditions
short statureSmall for gestational age (SGA)
Beyond the preview
Go deeper on NCT02770157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02770157.